ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,652Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 330

$867K Total Retail Price of All Prescriptions

Rank: 18 out of 330

657 Patients Receiving at Least One Drug in Part D
94% Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Hawaii
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 657 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

7% of this provider’s 657 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
PRAVASTATIN SODIUM 655 650* 101 1 9
SIMVASTATIN 525 520* 78 2 1
AMLODIPINE BESYLATE 504 482 76 3 3
ATORVASTATIN CALCIUM 500 471 69 4 2
OMEPRAZOLE 356 323 65 5 8
METOPROLOL SUCCINATE 346 328 50 6 11
LOSARTAN POTASSIUM 304 299* 60 7 4
METOPROLOL TARTRATE 300 276 44 8 17
PANTOPRAZOLE SODIUM 294 289* 49 9 31
CARVEDILOL 286 281* 44 10 22
FUROSEMIDE 258 238 46 11 12
NAMENDA 249 249 18 12 30
ALLOPURINOL 239 234* 38 13 13
WARFARIN SODIUM 235 235 35 14 23
JANUVIA 226 221* 30 15 29
COREG CR 216 211* 30 10 16 141
HYDROCHLOROTHIAZIDE 212 207* 41 17 16
RANITIDINE HCL 210 173 35 18 42
CLOPIDOGREL 198 172 32 19 15
DONEPEZIL HCL 194 194 26 20 26
LOSARTAN-HYDROCHLOROTHIAZIDE 188 188 27 21 19
LEVOTHYROXINE SODIUM 187 182* 35 22 6
METFORMIN HCL 168 163* 25 23 7
ZETIA 168 168 20 23 79
TAMSULOSIN HCL 164 151 31 25 21
FELODIPINE ER 153 153 21 26 25
LOVAZA 150 129 18 27 64
BISOPROLOL FUMARATE 149 149 23 28 132
AMLODIPINE-ATORVASTATIN 136 136 18 10 29 117
DIGOX 127 122* 25 30 92
CRESTOR 124 124 24 31 24
HYDROCODONE-ACETAMINOPHEN 122 101 37 S3 32 20
LISINOPRIL 120 105 23 33 5
JANUMET 118 101 24 34 80
METFORMIN HCL ER 118 118 19 34 36
ATENOLOL 107 102* 20 36 14
HYDRALAZINE HCL 94 89* 17 37 102
ISOSORBIDE MONONITRATE ER 91 91 15 38 93
LOVASTATIN 89 89 14 39 10
POLYETHYLENE GLYCOL 3350 85 80* 32 40 90
DIOVAN 84 84 14 41 34
DIGOXIN 80 75* 15 42 140
SYNTHROID 78 65 14 43 46
GLIPIZIDE ER 74 62 11 44 55
BENICAR 69 64* 13 45 76
GLIPIZIDE 62 62 12 46 28
VALSARTAN-HYDROCHLOROTHIAZIDE 62 <11 <11 46 60
TRIAMCINOLONE ACETONIDE 62 57* 41 46 56
ESCITALOPRAM OXALATE 61 <11 <11 49 65
NEXIUM 60 55* 13 50 51
SERTRALINE HCL 60 <11 <11 50 73
LYRICA 58 58 13 52 100
LABETALOL HCL 56 <11 <11 53 125
MUPIROCIN* 56 51* 44 53 107
EXFORGE 55 <11 <11 55 104
IRBESARTAN 54 <11 <11 56 39
ALENDRONATE SODIUM 53 <11 <11 57 18
ISOSORBIDE DINITRATE 53 48* 11 57 322
MICARDIS 51 <11 <11 59 205
POTASSIUM CHLORIDE 51 <11 <11 59 40
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.